1. Department of Cardiology and Cardiovascular Medicine, University of Tübingen, Tübingen, Germany;
2. Department of Cardiology, University Hospital Lübeck, Lübeck, Germany;
3. Bayer AG, Wuppertal, Germany;
4. Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands;
5. The Vascular Biology Center of Excellence,
6. Department of Internal Medicine,
7. Department of Microbiology, Immunology, and Biochemistry, and
8. Department of Surgery, University of Tennessee Health Science Center, Memphis, TN;
9. Joint Program of Biomedical Engineering, University of Tennessee Health Science Center and University of Memphis, Memphis, TN;
10. Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;
11. Division of Cardiology, University of Florida College of Medicine–Jacksonville, Jacksonville, FL;
12. Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy;
13. Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands; and
14. Center for Thrombosis and Haemostasis, Gutenberg University Medical Center, Mainz, Germany